CDI Biosciences develops technologies that increase the yield of bioproducts manufactured in cellular systems.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Madison
State: Wisconsin
Zip:
Country: United States
CDI Bioscience has developed an innovative technology for increased yield of bioproducts, manufactured in cellular systems. Genetic engineering technology is used to control the metabolism of cells, thus shifting the cell from replicative to production mode (RP Shift®). In particular, this technology has been designed for use in mammalian cells, unlocking their potential to produce proteins, peptides and enzymes. The current design of the technology can be readily translated to bacterial and yeast cellular systems for the production of commercial grade bioproducts.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2001 | PTC Therapeutics | Series D | 0 |
9/2001 | PTC Therapeutics | Series D | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2007 | Venture Round | 2 | $3M |
Battelle Ventures Innovation Valley Partners Battelle Ventures Innovation Valley Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|